A weighted Kaplan-Meier analysis was used to determine overall survival (OS) and breast cancer-specific mortality (BCSM), which were based on breast cancer subtype and HER2 status, of the patients in the subgroups. The gene discussed is ERBB2; the disease is breast carcinoma.